PMID- 37002039
OWN - NLM
STAT- MEDLINE
DCOM- 20231004
LR  - 20231007
IS  - 0219-3108 (Electronic)
IS  - 1015-9584 (Linking)
VI  - 46
IP  - 10
DP  - 2023 Oct
TI  - Comparison of single-anastomosis gastric bypass and sleeve gastrectomy on type 2 
      diabetes mellitus remission for obese patients: A meta-analysis of randomized 
      controlled trials.
PG  - 4152-4160
LID - S1015-9584(23)00368-8 [pii]
LID - 10.1016/j.asjsur.2023.03.062 [doi]
AB  - Currently, the increasing numbers of one anastomosis gastric bypass (OAGB) 
      brought this technique in the third position in order of frequency, behind sleeve 
      gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB). However, OAGB is still 
      considered lack of evidence in reducing obesity- related comorbidities. Our study 
      aimed to compare the efficacy for SG and OAGB improving type 2 diabetes mellitus 
      (T2DM) remission and weight loss in obese patients. PubMed, Embase, and the 
      Cochrane Central Register of Controlled Trials (CENTRAL) were searched for 
      randomized controlled trials (RCTs) comparing OAGB and SG. Review Manager 5.4.1 
      was used to analyze the data, and the right effect model was chosen based on 
      heterogeneity. Five randomized controlled trials were included in the study. The 
      remission of T2DM in the OAGB group was more efficient at 1 year and 5 years. 
      Meanwhile, the OAGB group has a greater improvement than the SG group in terms of 
      hypertension (HTN) and fasting plasma glucose (FPG). Although the percentage of 
      excess BMI loss (%EBMIL) between the OAGB and SG groups was not significant at 6 
      months, the OAGB group had a conspicuous %EBMIL at 1 year. And 5 years after 
      surgery, a higher percentage of excess weight loss (%EWL) was found in the OAGB 
      group. Besides, the OAGB group showed a lower body mass index (BMI) at 5 years 
      than the SG group, but the BMI at 6 months and 1 year were not significant. 
      Finally, at 6 months, the OAGB group exhibited a more remarkable percentage of 
      total weight loss (%TWL) than the SG group. In general, OAGB exhibited a better 
      therapeutic effect in T2DM, HTN, and weight loss than SG in the medium-term 
      follow-up period. To assess the long-term efficacy, clinics should be encouraged 
      to continue longer-term follow-up studies and possibly RCTs.
CI  - Copyright (c) 2023 Asian Surgical Association and Taiwan Robotic Surgery 
      Association. Published by Elsevier B.V. All rights reserved.
FAU - Ding, Zujun
AU  - Ding Z
AD  - Department of General Surgery, The Affiliated Hospital of Hangzhou Normal 
      University, Hangzhou, China.
FAU - Jin, Ling
AU  - Jin L
AD  - Key Laboratory of Adolescent Health Assessment and Exercise Intervention of 
      Ministry of Education, East China Normal University, Shanghai, China.
FAU - Song, Yu
AU  - Song Y
AD  - Department of Translational Medicine Platform, The Affiliated Hospital of 
      Hangzhou Normal University, Hangzhou, China.
FAU - Feng, Chenglei
AU  - Feng C
AD  - Department of General Surgery, The Affiliated Hospital of Hangzhou Normal 
      University, Hangzhou, China.
FAU - Shen, Pengfei
AU  - Shen P
AD  - Department of General Surgery, The Affiliated Hospital of Hangzhou Normal 
      University, Hangzhou, China.
FAU - Li, Hang
AU  - Li H
AD  - Department of General Surgery, The Affiliated Hospital of Hangzhou Normal 
      University, Hangzhou, China. Electronic address: hanglhznu@126.com.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
DEP - 20230329
PL  - Netherlands
TA  - Asian J Surg
JT  - Asian journal of surgery
JID - 8900600
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/complications/surgery
MH  - Gastrectomy/methods
MH  - *Gastric Bypass/methods
MH  - *Hypertension/surgery
MH  - Obesity/complications/surgery
MH  - *Obesity, Morbid/complications/surgery
MH  - Randomized Controlled Trials as Topic
MH  - Retrospective Studies
MH  - Treatment Outcome
MH  - Weight Loss
OTO - NOTNLM
OT  - Meta-analysis
OT  - Obesity
OT  - One anastomosis gastric bypass
OT  - Sleeve gastrectomy
OT  - Type 2 diabetes mellitus
COIS- Conflict of interest The authors declare that the research was conducted in the 
      absence of any commercial or financial relationships that could be construed as a 
      potential conflict of interest.
EDAT- 2023/04/01 06:00
MHDA- 2023/10/04 06:44
CRDT- 2023/03/31 22:03
PHST- 2022/09/24 00:00 [received]
PHST- 2023/02/27 00:00 [revised]
PHST- 2023/03/15 00:00 [accepted]
PHST- 2023/10/04 06:44 [medline]
PHST- 2023/04/01 06:00 [pubmed]
PHST- 2023/03/31 22:03 [entrez]
AID - S1015-9584(23)00368-8 [pii]
AID - 10.1016/j.asjsur.2023.03.062 [doi]
PST - ppublish
SO  - Asian J Surg. 2023 Oct;46(10):4152-4160. doi: 10.1016/j.asjsur.2023.03.062. Epub 
      2023 Mar 29.